Literature DB >> 22078107

Smart pump alerts: all that glitters is not gold.

Silvia Manrique-Rodríguez1, Amelia Sánchez-Galindo, Cecilia M Fernández-Llamazares, Jesús López-Herce, Lara Echarri-Martínez, Vicente Escudero-Vilaplana, María Sanjuro-Sáez, Angel Carrillo-Álvarez.   

Abstract

INTRODUCTION: The implementation of smart pump technology can reduce the incidence of errors in the administration of intravenous drugs. This approach involves developing drug libraries for specific units and setting hard and soft limits for each drug. If a programming error occurs and these limits are exceeded, an alarm sounds and the infusion can be blocked. A detailed analysis of these alarms is essential in order not to bias the results in favor of a positive impact of this technology.
PURPOSE: To evaluate the results of the first analysis of the use of smart infusion pumps and to assess the significance and practical implications of the alarms sounded.
METHODS: The study was performed by a multidisciplinary team that consisted of a clinical pharmacist, a pediatrician from the pediatric intensive care unit (PICU), and the chief nurse of the unit. A library of 108 drugs was developed over a 7-month period and introduced into 40 syringe pumps and 12 volumetric pumps (Alaris(®) with Plus software) before being applied in 6 of the 11 beds in the PICU. After four month's use, data were analyzed using the Guardrails(®) CQI v4.1 Event Reporter program.
RESULTS: Following the first four months of implementation, compliance with the drug library was 87%. By analyzing the alerts triggered, we were able to detect problems such as the need to increase user training, readjust limits that did not correspond to clinical practice, correct errors in the editing of the drug library and including a training profile.
CONCLUSION: It is difficult to obtain accurate data on the true impact of this technology in the early stages of its implementation. This preliminary analysis allowed us to identify improvement measures to distinguish, in future evaluations, the alarms triggered by a real programming error from those caused by incorrect use.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22078107     DOI: 10.1016/j.ijmedinf.2011.10.010

Source DB:  PubMed          Journal:  Int J Med Inform        ISSN: 1386-5056            Impact factor:   4.046


  6 in total

Review 1.  Benefits and risks of using smart pumps to reduce medication error rates: a systematic review.

Authors:  Kumiko Ohashi; Olivia Dalleur; Patricia C Dykes; David W Bates
Journal:  Drug Saf       Date:  2014-12       Impact factor: 5.606

Review 2.  Clinical Decision Support: a 25 Year Retrospective and a 25 Year Vision.

Authors:  B Middleton; D F Sittig; A Wright
Journal:  Yearb Med Inform       Date:  2016-08-02

3.  A Multi-hospital Before-After Observational Study Using a Point-Prevalence Approach with an Infusion Safety Intervention Bundle to Reduce Intravenous Medication Administration Errors.

Authors:  Kumiko O Schnock; Patricia C Dykes; Jennifer Albert; Deborah Ariosto; Caitlin Cameron; Diane L Carroll; Moreen Donahue; Adrienne G Drucker; Rosemary Duncan; Linda Fang; Marla Husch; Nicole McDonald; Ray R Maddox; Julie McGuire; Sally Rafie; Emilee Robertson; Melinda Sawyer; Elizabeth Wade; Catherine S Yoon; Stuart Lipsitz; David W Bates
Journal:  Drug Saf       Date:  2018-06       Impact factor: 5.606

Review 4.  New technologies as a strategy to decrease medication errors: how do they affect adults and children differently?

Authors:  Margarita Ruano; Elena Villamañán; Ester Pérez; Alicia Herrero; Rodolfo Álvarez-Sala
Journal:  World J Pediatr       Date:  2015-12-18       Impact factor: 2.764

5.  Quantifying the Impact of Infusion Alerts and Alarms on Nursing Workflows: A Retrospective Analysis.

Authors:  Denny Yu; Marian Obuseh; Poching DeLaurentis
Journal:  Appl Clin Inform       Date:  2021-06-30       Impact factor: 2.762

6.  Smart pumps improve medication safety but increase alert burden in neonatal care.

Authors:  Kristin R Melton; Kristen Timmons; Kathleen E Walsh; Jareen K Meinzen-Derr; Eric Kirkendall
Journal:  BMC Med Inform Decis Mak       Date:  2019-11-07       Impact factor: 2.796

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.